Durable Viral Suppression Among Persons with HIV in the Deep South: an Observational Study

Overview

Journal AIDS Care

Publisher Informa Healthcare

Specialty Infectious Diseases

Date 2022 Oct 19

PMID 36259779

Authors

Drenna Waldrop

Raphiel Murden

Mary Claire Montilus

Monique Balthazar

Crista Irwin

Marcia Holstad

Raymond L Ownby

Affiliations

Soon will be listed here.

Abstract

This study assessed predictors of stable HIV viral suppression in a racially diverse sample of persons living with HIV (PWH) in the southern US. A total of 700 PWH were recruited from one of four HIV clinics in Metro Atlanta, GA. Data were collected from September 2012 to July 2017, and HIV viral loads were retrieved from EMR for 18 months. The baseline visits and EMR data were used for current analyses. Durable viral suppression was categorized as 1. Remain suppressed, 2. Remain unsuppressed, and 3. Unstable suppression. The number of antiretroviral medications and age were significantly associated with durable viral suppression. Older age, fewer ART medications and availability of social support were positively associated with durable viral suppression over the 18-month observation period. Findings suggest that regimen complexity is potentially a better predictor of viral suppression than self-reported medication adherence. The need for consensus on the definition of durable viral suppression is also urged.

References

Kemp C, Lipira L, Huh D, Nevin P, Turan J, Simoni J . HIV stigma and viral load among African-American women receiving treatment for HIV. AIDS. 2019; 33(9):1511-1519. PMC: 6621603. DOI: 10.1097/QAD.0000000000002212. View

Anderson A, Haardorfer R, McDonnell Holstad M, Nguyen M, Waldrop-Valverde D . Predictors of disparities in retention in care among African Americans living with HIV. AIDS Care. 2020; 33(1):54-62. PMC: 7375945. DOI: 10.1080/09540121.2020.1717423. View

Ghidei L, Simone M, Salow M, Zimmerman K, Paquin A, Skarf L . Aging, antiretrovirals, and adherence: a meta analysis of adherence among older HIV-infected individuals. Drugs Aging. 2013; 30(10):809-19. PMC: 3844933. DOI: 10.1007/s40266-013-0107-7. View

Stone V, Clarke J, Lovell J, Steger K, Hirschhorn L, Boswell S . HIV/AIDS patients' perspectives on adhering to regimens containing protease inhibitors. J Gen Intern Med. 1998; 13(9):586-93. PMC: 1497015. DOI: 10.1046/j.1525-1497.1998.00180.x. View

Ownby R, Waldrop-Valverde D, Hardigan P, Caballero J, Jacobs R, Acevedo A . Development and validation of a brief computer-administered HIV-Related Health Literacy Scale (HIV-HL). AIDS Behav. 2012; 17(2):710-8. PMC: 3562365. DOI: 10.1007/s10461-012-0301-3. View

Marks G, Patel U, Stirratt M, Mugavero M, Mathews W, Giordano T . Single Viral Load Measurements Overestimate Stable Viral Suppression Among HIV Patients in Care: Clinical and Public Health Implications. J Acquir Immune Defic Syndr. 2016; 73(2):205-12. PMC: 5964607. DOI: 10.1097/QAI.0000000000001036. View

Samji H, Cescon A, Hogg R, Modur S, Althoff K, Buchacz K . Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013; 8(12):e81355. PMC: 3867319. DOI: 10.1371/journal.pone.0081355. View

ONeil C, Palmer A, Coulter S, OBrien N, Shen A, Zhang W . Factors associated with antiretroviral medication adherence among HIV-positive adults accessing highly active antiretroviral therapy (HAART) in British Columbia, Canada. J Int Assoc Physicians AIDS Care (Chic). 2012; 11(2):134-41. DOI: 10.1177/1545109711423976. View

Tanner Z, Lachowsky N, Ding E, Samji H, Hull M, Cescon A . Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort. BMC Infect Dis. 2016; 16(1):590. PMC: 5073906. DOI: 10.1186/s12879-016-1926-z. View

10.

Zolopa A . The evolution of HIV treatment guidelines: current state-of-the-art of ART. Antiviral Res. 2009; 85(1):241-4. DOI: 10.1016/j.antiviral.2009.10.018. View

11.

Maragh-Bass A, Denison J, Thorpe Jr R, Knowlton A . The interactive effects of social support and physical functioning on HIV medical outcomes among African Americans whom inject drugs. J Ethn Subst Abuse. 2017; 17(4):401-419. PMC: 6964256. DOI: 10.1080/15332640.2016.1264337. View

12.

Anderson A, Monda A, Haardorfer R, Waldrop-Valverde D . Relationship Between Depressive Symptoms and Engagement With the Health Care Provider in People Living With HIV: A Two-Wave Cross-Lag Model. J Assoc Nurses AIDS Care. 2019; 30(4):384-391. DOI: 10.1097/JNC.0000000000000041. View

13.

Waldrop-Valverde D, Jones D, Gould F, Kumar M, Ownby R . Neurocognition, health-related reading literacy, and numeracy in medication management for HIV infection. AIDS Patient Care STDS. 2010; 24(8):477-84. PMC: 2958450. DOI: 10.1089/apc.2009.0300. View

14.

Osborn C, Paasche-Orlow M, Davis T, Wolf M . Health literacy: an overlooked factor in understanding HIV health disparities. Am J Prev Med. 2007; 33(5):374-8. DOI: 10.1016/j.amepre.2007.07.022. View

15.

Thakarar K, Morgan J, Gaeta J, Hohl C, Drainoni M . Homelessness, HIV, and Incomplete Viral Suppression. J Health Care Poor Underserved. 2016; 27(1):145-156. PMC: 4982659. DOI: 10.1353/hpu.2016.0020. View

16.

Diepstra K, Lu H, McManus K, Rogawski McQuade E, Rhodes A, Westreich D . What we talk about when we talk about durable viral suppression. AIDS. 2020; 34(11):1683-1686. PMC: 7845768. DOI: 10.1097/QAD.0000000000002612. View

17.

Waldrop-Valverde D, Guo Y, Ownby R, Rodriguez A, Jones D . Risk and protective factors for retention in HIV care. AIDS Behav. 2013; 18(8):1483-91. PMC: 3975732. DOI: 10.1007/s10461-013-0633-7. View

18.

Pilcher C, Ospina-Norvell C, Dasgupta A, Jones D, Hartogensis W, Torres S . The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting. J Acquir Immune Defic Syndr. 2016; 74(1):44-51. PMC: 5140684. DOI: 10.1097/QAI.0000000000001134. View

19.

Kalichman S, Simbayi L, Cloete A, Mthembu P, Mkhonta R, Ginindza T . Measuring AIDS stigmas in people living with HIV/AIDS: the Internalized AIDS-Related Stigma Scale. AIDS Care. 2008; 21(1):87-93. DOI: 10.1080/09540120802032627. View

20.

Christopoulos K, Neilands T, Hartogensis W, Geng E, Sauceda J, Mugavero M . Internalized HIV Stigma Is Associated With Concurrent Viremia and Poor Retention in a Cohort of US Patients in HIV Care. J Acquir Immune Defic Syndr. 2019; 82(2):116-123. PMC: 6750269. DOI: 10.1097/QAI.0000000000002117. View